PLENABON Trademark

Trademark Overview

On Wednesday, June 27, 2012, a trademark application was filed for PLENABON with the United States Patent and Trademark Office. The USPTO has given the PLENABON trademark a serial number of 85662465. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Friday, November 20, 2015. This trademark is owned by Pfizer Inc.. The PLENABON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
plenabon

General Information

Serial Number85662465
Word MarkPLENABON
Filing DateWednesday, June 27, 2012
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateFriday, November 20, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 9, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateFriday, November 20, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Friday, November 20, 2015ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Friday, November 20, 2015ABANDONMENT - AFTER PUBLICATION
Thursday, November 19, 2015TEAS EXPRESS ABANDONMENT RECEIVED
Friday, June 5, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 4, 2015EXTENSION 5 GRANTED
Monday, June 1, 2015EXTENSION 5 FILED
Monday, June 1, 2015TEAS EXTENSION RECEIVED
Wednesday, November 19, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 18, 2014EXTENSION 4 GRANTED
Monday, November 17, 2014EXTENSION 4 FILED
Monday, November 17, 2014TEAS EXTENSION RECEIVED
Friday, May 23, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 22, 2014EXTENSION 3 GRANTED
Monday, May 19, 2014EXTENSION 3 FILED
Monday, May 19, 2014TEAS EXTENSION RECEIVED
Friday, November 22, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 21, 2013EXTENSION 2 GRANTED
Tuesday, November 19, 2013EXTENSION 2 FILED
Tuesday, November 19, 2013TEAS EXTENSION RECEIVED
Saturday, May 18, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 17, 2013EXTENSION 1 GRANTED
Tuesday, May 14, 2013EXTENSION 1 FILED
Tuesday, May 14, 2013TEAS EXTENSION RECEIVED
Tuesday, April 2, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 29, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 28, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 28, 2013TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, December 4, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 9, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 9, 2012PUBLISHED FOR OPPOSITION
Wednesday, September 19, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 23, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 23, 2012ASSIGNED TO EXAMINER
Thursday, July 5, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, June 30, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

plenabon preparations pharmaceutical dysfunction treatment cancer diabetes sexual pain disorders diseases